Related Experiment Videos
[Recent changes in breast cancer surgery]
1Országos Reumatológiaiés Fizioterápiás Intézet Sebészeti Osztálya, Budapest.
Orvosi Hetilap
|May 26, 1996
Summary
Breast cancer surgery is shifting towards minimal intervention, focusing on local recurrence and potentially omitting irradiation and axillary dissection. Intraoperative lymph node mapping and timing surgery to the menstrual cycle show promise for improved outcomes.
Area of Science:
- Oncology
- Surgical Oncology
- Breast Cancer Research
Context:
- Shift from radical mastectomy towards breast-conserving surgery.
- Growing evidence on the impact of surgical margins and intraductal components on local recurrence.
- Exploration of de-escalation strategies in breast cancer treatment, including reduced irradiation and axillary dissection.
Purpose:
- To review current trends in breast cancer surgery, emphasizing the principle of necessary minimum intervention.
- To discuss the role of surgical margins, intraductal components, and axillary lymph node status in local recurrence.
- To evaluate novel approaches like intraoperative lymph node mapping and the prognostic significance of hepatocyte growth factor.
- To investigate the potential survival benefits of timing breast cancer surgery to the menstrual cycle.
Summary:
- Modern breast cancer surgery prioritizes minimal intervention, moving away from radical procedures.
- Local recurrence is linked to intact surgical margins and the extent of intraductal components.
- Less aggressive treatment strategies include omitting irradiation in select cases and reconsidering routine axillary dissection.
- Intraoperative lymph node mapping shows promise for assessing tumor involvement, potentially replacing the prognostic role of dissection.
- Hepatocyte growth factor may serve as an alternative prognostic marker.
- Operating during the luteal phase of the menstrual cycle appears to improve survival rates.
Impact:
- Potential for reduced morbidity and improved quality of life for breast cancer patients.
- Advancements in surgical decision-making regarding extent of resection and axillary staging.
- Development of more personalized and effective breast cancer treatment protocols.
- Identification of novel biomarkers for prognostication and treatment guidance.